Kenneth O'Keefe - Mar 7, 2023 Form 4 Insider Report for Jazz Pharmaceuticals plc (JAZZ)

Role
Director
Signature
By: /s/Adam Guttmann, as attorney in fact For: Kenneth W O'Keefe
Stock symbol
JAZZ
Transactions as of
Mar 7, 2023
Transactions value $
-$4,347
Form type
4
Date filed
3/9/2023, 05:34 PM
Previous filing
Aug 9, 2022
Next filing
Aug 15, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction JAZZ Ordinary Shares Options Exercise $368K +4.5K +21.35% $81.76 25.6K Mar 7, 2023 Direct
transaction JAZZ Ordinary Shares Sale -$372K -2.69K -10.52% $138.39 22.9K Mar 7, 2023 Direct F1
holding JAZZ Ordinary Shares 4.45K Mar 7, 2023 by Trust F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction JAZZ Non-Qualified Stock Option (right to buy) Options Exercise $0 -4.5K -100% $0.00* 0 Mar 7, 2023 Ordinary Shares 4.5K $81.76 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold to pay option price from the exercise of stock options.
F2 Shares are held for the benefit of The Kenneth W. O'Keefe Trust U/A/D 2/12/1997, of which the reporting person is both trustee and beneficiary.
F3 This option was granted pursuant to the Issuer's 2007 Non-Employee Directors Stock Option Plan. This option vested in 12 equal monthly installments beginning on September 1, 2013.